Clinical Trials Browser

Phase 3 × Not yet recruiting × Cetuximab × Clear all

NCT07595276 2026-05-19

Comparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.

Phase 3 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Phase 3 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07549399 2026-04-24

CRITⅡ

Phase 3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

NCT07432087 2026-02-25

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 3 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT07004413 2025-06-04

FIRE-11

Phase 3 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06647563 2024-10-18

Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)

Phase 3 Not yet recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

NCT06616259 2024-09-27

CAPCET-III

Phase 3 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05948072 2023-07-17

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Phase 3 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms